These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14306336)

  • 1. CIRCULATING INTERFERON AFTER MEASLES VACCINATION.
    PETRALLI JK; MERIGAN TC; WILBUR JR
    N Engl J Med; 1965 Jul; 273():198-201. PubMed ID: 14306336
    [No Abstract]   [Full Text] [Related]  

  • 2. CLINICAL AND SEROLOGICAL OBSERVATIONS ON THE CHILDREN GIVEN ATTENUATED MEASLES VACCINE.
    ARAI M; NAKAMURA M; AKAMATSU T; KIMURA M; KITAYAMA T; KOIDE G
    Acta Paediatr Jpn; 1963 Dec; 14():9-16. PubMed ID: 14200614
    [No Abstract]   [Full Text] [Related]  

  • 3. VACCINATION AGAINST MEASLES.
    ENDERS JF
    Aust J Exp Biol Med Sci; 1963 Aug; 41():SUPPL467-89. PubMed ID: 14058869
    [No Abstract]   [Full Text] [Related]  

  • 4. INACTIVATED MEASLES VIRUS VACCINE SUBSEQUENTLY CHALLENGED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
    KIMURA M; ISHIGURO Y
    Jpn J Med Sci Biol; 1965 Feb; 18():65-71. PubMed ID: 14300296
    [No Abstract]   [Full Text] [Related]  

  • 5. MEASLES VACCINATION. I. SEROLOGIC RESPONSES TO AN INACTIVATED VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S; CARLSTROEM G
    Arch Gesamte Virusforsch; 1963 Aug; 13():548-58. PubMed ID: 14085248
    [No Abstract]   [Full Text] [Related]  

  • 6. [FURTHER OBSERVATIONS ON THE PROTECTIVE EFFECTS AND SEROLOGICAL RESPONSE IN CHILDREN IMMUNIZED WITH KILLED MEASLES VIRUS VACCINE].
    BRANCATO P; GULLO A; ALBANESE M
    Riv Ist Sieroter Ital; 1964; 39():287-92. PubMed ID: 14177289
    [No Abstract]   [Full Text] [Related]  

  • 7. COMBINED USE OF HUMAN GAMMA-GLOBULIN AND LIVE MEASLES-VIRUS VACCINE WITH REFERENCE TO SINGLE INOCULATION OF LIVE MEASLES-VIRUS VACCINE IN EARLY INFANCY.
    FUJII R; MINAMITANI M; NAKAMURA K
    Jpn J Med Sci Biol; 1965 Feb; 18():56-64. PubMed ID: 14300295
    [No Abstract]   [Full Text] [Related]  

  • 8. MEASLES VACCINATION. IV. RESPONSES TO TWO DIFFERENT TYPES OF PREPARATIONS GIVEN AS A FOURTH DOSE OF VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S
    Br Med J; 1965 Mar; 1(5438):813-7. PubMed ID: 14258844
    [No Abstract]   [Full Text] [Related]  

  • 9. IMMUNIZATION AGAINST MEASLES: DEVELOPMENT AND EVALUATION OF A HIGHLY ATTENUATED LIVE MEASLES VACCINE.
    SCHWARZ AJ
    Ann Paediatr; 1964; 202():241-52. PubMed ID: 14140673
    [No Abstract]   [Full Text] [Related]  

  • 10. MEASLES VACCINATION.
    PARKER WL
    Can Med Assoc J; 1964 Nov; 91(20):1079-80. PubMed ID: 14214232
    [No Abstract]   [Full Text] [Related]  

  • 11. GLOBULIN-MODIFIED VACCINATION WITH LIVE ATTENUATED MEASLES VIRUS, SUGIYAMA, ADAPTED TO BOVINE RENAL CELLS.
    MINAMITANI M; NAKAMURA K; SHINOZAKI T; TAKAHASHI T; FUJII R; SABURI Y; MATUMOTO M
    Jpn J Exp Med; 1964 Apr; 34():85-8. PubMed ID: 14171677
    [No Abstract]   [Full Text] [Related]  

  • 12. [EXPERIENCE IN VACCINATION WITH ATTENUATED MEASLES VIRUS. 3. IMMUNOLOGIC AND EPIDEMIOLOGIC STUDY AFTER A YEAR OF OBSERVATION].
    HEVIA P; RODRIGUEZ M; UNDURRAGA O; ROSSELOT J; MENEGHELLO J
    Pediatria (Santiago); 1963; 6():151-6. PubMed ID: 14080014
    [No Abstract]   [Full Text] [Related]  

  • 13. [VIROLOGICAL AND CLINICAL OBSERVATIONS FOLLOWING ACTIVE MEASLES IMMUNIZATION].
    HAAS R; VIVELL O; GAEDECKE R; SIGNER E; SCHUMACHER H; BERTHOLD H
    Dtsch Med Wochenschr; 1965 Jan; 90():193-200. PubMed ID: 14240834
    [No Abstract]   [Full Text] [Related]  

  • 14. [VACCINATION AGAINST MEASLES].
    DE BRITO MM
    J Soc Cienc Med Lisb; 1964 Dec; 128():742-58. PubMed ID: 14307564
    [No Abstract]   [Full Text] [Related]  

  • 15. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEASLES IMMUNIZATION WITH KILLED VIRUS VACCINE. SERUM ANTIBODY TITERS AND EXPERIENCE WITH EXPOSURE TO MEASLES EPIDEMIC.
    RAUH LW; SCHMIDT R
    Am J Dis Child; 1965 Mar; 109():232-7. PubMed ID: 14246070
    [No Abstract]   [Full Text] [Related]  

  • 17. DATA OF THE INVESTIGATION ON THE EFFECTIVENESS OF ACTIVE IMMUNIZATION AGAINST MEASLES WITH VARIOUS LIVE VACCINES AND COMBINATIONS THEREOF.
    FADEEVA LL; ZHDANOV VM
    Arch Gesamte Virusforsch; 1965; 16():524-6. PubMed ID: 14322928
    [No Abstract]   [Full Text] [Related]  

  • 18. Observation of the protective effect of live measles vaccines in the first year after vaccination.
    Sejda J; Helcl J; Strauss J
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(3):288-95. PubMed ID: 4161911
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 20. ACTION OF ENDOGENOUS INTERFERON AGAINST VACCINIA INFECTION IN CHILDREN.
    PETRALLI JK; MERIGAN TC; WILBUR JR
    Lancet; 1965 Aug; 2(7409):401-5. PubMed ID: 14346758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.